GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GRI Bio Commences Patient Enrollment in Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis ("IPF") tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
GRI Bio (NASDAQ:GRI) CEO Marc Hertz joined Steve Darling from Proactive to share news the company has begun patient enrollment in a Phase 2a biomarker study.
GRI Bio, Inc (GRI) Announces FDA Clearance of IND for Lead Program GRI-0621 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Immune NK T-cells may be therapeutic target for IPF pulmonaryfibrosisnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pulmonaryfibrosisnews.com Daily Mail and Mail on Sunday newspapers.